Brain

IRLAB Reports Continued Progress Ahead of the Mesdopetam Phase III Program

GOTHENBURG, SWEDEN / ACCESSWIRE / October 29, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A), a company…

2 months ago

Alimetry revolutionises gut health diagnosis by integrating AI into its wearable device, raises US $18m to fuel next phase of growth

MINNEAPOLIS, Oct. 28, 2024 /PRNewswire/ -- Alimetry has raised an oversubscribed US $18m A2 financing round to commercialise its wearable gut…

2 months ago

Fountain Life Develops “Zora AI,” the World’s First Generative AI Platform Specially Trained in Functional and Longevity Medicine

LAKE NONA, Fla., Oct. 28, 2024 /PRNewswire/ -- Fountain Life, a company that offers longevity, preventative health, advanced diagnostics, and…

2 months ago

IRLAB: Invitation to the Interim Report for Q3 2024 Presentation and Webcast

GOTHENBURG, SWEDEN / ACCESSWIRE / October 28, 2024 / IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A), a company discovering and developing…

3 months ago

Nexalin Technology Announces Landmark Study on Alzheimer’s Disease and Deep Intracranial Frequency Stimulation Published in Journal of Alzheimer’s Disease

New Data Confirms DIFS Improves Cognitive Function and Restores Brain Activity in Alzheimer's Patients HOUSTON, TX, Oct. 28, 2024 (GLOBE…

3 months ago

AlzeCure Presents New Positive Data for the TrkA-NAM Pain Project Against Osteoarthritis

STOCKHOLM, SE / ACCESSWIRE / October 28, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical…

3 months ago

Firefly Neuroscience Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

TORONTO, Oct. 25, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly,” or the “Company”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”)…

3 months ago

Neuromorphic Computing Market worth $1,325.2 million by 2030 – Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., Oct. 25, 2024 /PRNewswire/ -- The neuromorphic computing market is expected to grow from USD 28.5 million in 2024…

3 months ago

Vesalio Announces Clinical Study Initiative for the Recently Launched pVasc Thrombectomy System and Planned Attendance at TCT, VIVA, and VEITH Meetings

Vesalio Introduces pVasc™ U.S. clinical study initiative to capture real-world data and optimize results for patients suffering from peripheral vascular disease …

3 months ago

Acasti Announces Corporate Name Change to Grace Therapeutics, Inc.

Name Change Reflects Extensive Scientific and Corporate Brand Equity Previously Established under Grace Therapeutics Grace Therapeutics will begin trading on…

3 months ago